1-112619878-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2
The NM_006135.3(CAPZA1):c.34G>A(p.Glu12Lys) variant causes a missense change. The variant allele was found at a frequency of 0.0037 in 1,611,892 control chromosomes in the GnomAD database, including 26 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.0023 ( 2 hom., cov: 33)
Exomes 𝑓: 0.0038 ( 24 hom. )
Consequence
CAPZA1
NM_006135.3 missense
NM_006135.3 missense
Scores
3
7
9
Clinical Significance
Conservation
PhyloP100: 6.19
Genes affected
CAPZA1 (HGNC:1488): (capping actin protein of muscle Z-line subunit alpha 1) CAPZA1 is a member of the F-actin capping protein alpha subunit family. This gene encodes the alpha subunit of the barbed-end actin binding protein. The protein regulates growth of the actin filament by capping the barbed end of growing actin filaments. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.012323827).
BP6
Variant 1-112619878-G-A is Benign according to our data. Variant chr1-112619878-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 1206064.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chr1-112619878-G-A is described in Lovd as [Benign]. Variant chr1-112619878-G-A is described in Lovd as [Likely_benign].
BS2
High AC in GnomAd4 at 343 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CAPZA1 | NM_006135.3 | c.34G>A | p.Glu12Lys | missense_variant | 1/10 | ENST00000263168.4 | NP_006126.1 | |
CAPZA1 | XM_017002424.3 | c.34G>A | p.Glu12Lys | missense_variant | 1/10 | XP_016857913.1 | ||
CAPZA1 | XM_011542225.4 | c.34G>A | p.Glu12Lys | missense_variant | 1/9 | XP_011540527.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CAPZA1 | ENST00000263168.4 | c.34G>A | p.Glu12Lys | missense_variant | 1/10 | 1 | NM_006135.3 | ENSP00000263168.3 |
Frequencies
GnomAD3 genomes AF: 0.00225 AC: 343AN: 152228Hom.: 2 Cov.: 33
GnomAD3 genomes
AF:
AC:
343
AN:
152228
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00193 AC: 472AN: 244770Hom.: 5 AF XY: 0.00203 AC XY: 270AN XY: 132836
GnomAD3 exomes
AF:
AC:
472
AN:
244770
Hom.:
AF XY:
AC XY:
270
AN XY:
132836
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00385 AC: 5619AN: 1459546Hom.: 24 Cov.: 30 AF XY: 0.00376 AC XY: 2731AN XY: 725964
GnomAD4 exome
AF:
AC:
5619
AN:
1459546
Hom.:
Cov.:
30
AF XY:
AC XY:
2731
AN XY:
725964
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00225 AC: 343AN: 152346Hom.: 2 Cov.: 33 AF XY: 0.00227 AC XY: 169AN XY: 74504
GnomAD4 genome
AF:
AC:
343
AN:
152346
Hom.:
Cov.:
33
AF XY:
AC XY:
169
AN XY:
74504
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
12
ALSPAC
AF:
AC:
25
ESP6500AA
AF:
AC:
3
ESP6500EA
AF:
AC:
33
ExAC
AF:
AC:
221
Asia WGS
AF:
AC:
1
AN:
3478
ClinVar
Significance: Likely benign
Submissions summary: Benign:3
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Likely benign, no assertion criteria provided | clinical testing | Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC) | - | - - |
not specified Benign:1
Benign, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, University Medical Center Utrecht | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Uncertain
T
BayesDel_noAF
Pathogenic
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D
M_CAP
Benign
T
MetaRNN
Benign
T
MetaSVM
Benign
T
MutationAssessor
Benign
L
PrimateAI
Pathogenic
D
PROVEAN
Uncertain
D
REVEL
Benign
Sift
Benign
T
Sift4G
Benign
T
Polyphen
B
Vest4
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at